Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: A nationwide survey in the Netherlands-Reference-Cited by-同舟云学术

Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: A nationwide survey in the Netherlands

Published:2008-11-01 Issue:11 Volume:23 Page:3534-3538
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrology Dialysis Transplantation

Author:

Hofstra J. M.,Wetzels J. F. M.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/23/11/3534/7630445/gfn350.pdf

Reference10 articles.

1. Idiopathic Membranous Nephropathy: Outline and Rationale of a Treatment Strategy

2. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate

3. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy11See Editorial by Cattran, p. 349.

4. Immunosuppressive treatment for idiopathic membranous nephropathy: A systematic review

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membranous nephropathy: the current state of the problem;KIDNEYS;2023-07-11

2. Lipoic acid supplementation associated with neural epidermal growth factor-like 1 (NELL1)–associated membranous nephropathy;Kidney International;2021-12

3. Membranous nephropathy: thinking through the therapeutic options;Nephrology Dialysis Transplantation;2017-01-01

4. Treatment pattern in patients with idiopathic membranous nephropathy—practices in Sweden at the start of the millennium;Clinical Kidney Journal;2016-01-27

5. Évaluation d’une stratégie standardisée de prise en charge de la glomérulonéphrite extramembraneuse idiopathique au sein d’un réseau de santé en Lorraine (Néphrolor);Néphrologie & Thérapeutique;2015-02